Annie Luetkemeyer, MD, professor of infectious diseases at UCSF, is an expert on the treatment of viral infections. Robert Wachter, MD, MHM, chair of the UCSF Department of Medicine, interviewed her about the evidence behind potential treatments for COVID-19 (including chloroquine/hydroxychloroquine, remdesivir, and others), as well as how to assess new and existing drugs in a pandemic.
Clinical
Treatment options for COVID-19: Dr. Annie Luetkemeyer
Next Article:
Comments ()
Clinical
-
Despite guidelines, controversy remains over corticosteroids in COVID-19 -
-
-
-
Scientific doubt tempers COVID-19 vaccine optimism -
-
Placental injury reported in women with COVID-19 -
SARS-CoV-2 infection rate 16% in asymptomatic pregnant women at delivery -
Whether to test laboring women for SARS-CoV-2 may hinge on regional prevalence -
A long road to recovery: Lung rehab needed after COVID-19
Quality
Public Policy
Practice Management
-
-
-
AAN publishes ethical guidance on patient care during the pandemic -
Hazard pay included in new COVID-19 relief bill -
-
-
-
-
-
COVID-19: Eight steps for getting ready to see patients again
From the Society
Video
-
Critical care and COVID-19: Dr. Matt Aldrich -
Treatment options for COVID-19: Dr. Annie Luetkemeyer -
Managing the COVID-19 isolation floor at UCSF Medical Center -
-
